MELI drops 37 percent from highs despite 30 percent YoY growth streak, Jonah Lupton notes

MELI drops 37 percent from highs despite 30 percent YoY growth streak, Jonah Lupton notes
MELI extends growth streak, falls 37 percent

Jonah Lupton describes MELI as one of the most successful publicly traded companies, pointing out its unique record of achieving at least 30 percent year-over-year growth for more than 30 consecutive quarters.

He also notes that MELI is currently down 37 percent from its July 2025 highs.

Lupton's assessment of MELI's sustained growth and current valuation aligns with his broader observations on market dynamics, such as the heightened volatility reflected by the spike in HIMS short interest. His perspective on sector innovation also extends to advancements in healthcare, notably highlighting TMDX's efforts to address viable kidney wastage through technology.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.